Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention

Richard G. Jung(University of Ottawa), Benjamin Hibbert(Mayo Clinic), Jordan Bernick(University of Ottawa), Caleb Sypkes(University of Ottawa), Jeffrey A. Marbach(Tufts Medical Center), Katlyn Taylor(Ottawa Hospital), Anne‐Claire Duchez(Canadian Natural Resources), David T. Harnett(University of Ottawa), Sarah Visintini(University of Ottawa), Simon Parlow(University of Ottawa), Paul Boland(University of Ottawa), Shan Dhaliwal(Institute for Clinical Evaluative Sciences), Omar Abdel‐Razek(University of Ottawa), Alisha Labinaz(University of Ottawa), Pietro Di Santo(University of Ottawa), Trevor Simard(University of Ottawa), Joanne Joseph(University of Ottawa), F. Daniel Ramirez(University of Ottawa), Robert B. Moreland(University of Ottawa), Kiran Sarathy(University of Ottawa)
Thrombosis Research
April 24, 2020
Cited by 10


Related Papers